MedPath

Clobetasol Propionate

These highlights do not include all the information needed to use CLOBETASOL PROPIONATE FOAM safely and effectively. See full prescribing information for CLOBETASOL PROPIONATE FOAM. CLOBETASOL PROPIONATE foam, for topical useInitial U.S. Approval: 1985

Approved
Approval ID

db8c7a36-e950-44b9-b2ff-7fede2e87407

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 12, 2023

Manufacturers
FDA

Glenmark Pharmaceuticals Inc., USA

DUNS: 130597813

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

clobetasol propionate

PRODUCT DETAILS

NDC Product Code68462-608
Application NumberANDA210809
Marketing CategoryC73584
Route of AdministrationTOPICAL
Effective DateJune 21, 2022
Generic Nameclobetasol propionate

INGREDIENTS (9)

CETYL ALCOHOLInactive
Code: 936JST6JCN
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
CLOBETASOL PROPIONATEActive
Quantity: 0.5 mg in 1 g
Code: 779619577M
Classification: ACTIB
POTASSIUM CITRATEInactive
Code: EE90ONI6FF
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4M
Classification: IACT
STEARYL ALCOHOLInactive
Code: 2KR89I4H1Y
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Clobetasol Propionate - FDA Approval | MedPath